Literature DB >> 17889499

Aggregatibacter actinomycetemcomitans induces MMP-9 expression and proatherogenic lipoprotein profile in apoE-deficient mice.

Anita M Tuomainen1, Matti Jauhiainen, Petri T Kovanen, Jari Metso, Susanna Paju, Pirkko J Pussinen.   

Abstract

Periodontitis increases the atherosclerosis risk, but information on the role of periodontal pathogens in atherogenesis is limited. In the present study we have investigated, whether the major periodontal pathogen, Aggregatibacter (Actinobacillus) actinomycetemcomitans, induces development of atherosclerosis in apolipoprotein E-deficient mice. The mice received 4, 6, or 8 weekly i.v. injections of live pathogen (10(7)CFU/50 microl/mouse) or saline as control, and were killed 1 week after the last injection. The atherosclerotic lesion formation was examined from whole aortas and aortic sinus cryosections after lipid staining. Neither the lesion area in the aortas or en face analyses, nor their immunoreactivity to the macrophage-marker CD68 differed significantly between the infected and the control mice. However, the pathogen administration increased serum C-reactive protein (CRP) concentrations, and induced proatherogenic lipoprotein profiles with smaller particle sizes in very-low density (VLDL), low density (LDL), and high density (HDL) lipoprotein fractions. It also caused elevated matrix metalloproteinase-9 expression in the aortas and increased serum gelatinase level. Lipopolysaccharide deriving from the pathogen was associated with proatherogenic lipoprotein fractions: VLDL and especially LDL. The results indicate that A. actinomycetemcomitans contributes to disturbed lipoprotein profiles, inflammatory reaction, and matrix remodelling which are known to promote the development of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17889499     DOI: 10.1016/j.micpath.2007.08.011

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  12 in total

Review 1.  Inflammatory mechanisms linking periodontal diseases to cardiovascular diseases.

Authors:  Harvey A Schenkein; Bruno G Loos
Journal:  J Clin Periodontol       Date:  2013-04       Impact factor: 8.728

Review 2.  Mechanisms involved in the association between periodontal diseases and cardiovascular disease.

Authors:  R Teles; C-Y Wang
Journal:  Oral Dis       Date:  2011-01-11       Impact factor: 3.511

3.  Lipoproteins and lipoprotein metabolism in periodontal disease.

Authors:  Rachel Griffiths; Suzanne Barbour
Journal:  Clin Lipidol       Date:  2010-06

4.  Retinol-binding protein 4 : a possible role in cardiovascular complications.

Authors:  Jogeswar Mohapatra; Manoranjan Sharma; Aviseka Acharya; Gaurav Pandya; Abhijit Chatterjee; R Balaraman; Mukul R Jain
Journal:  Br J Pharmacol       Date:  2011-12       Impact factor: 8.739

Review 5.  Cardiovascular Diseases and Periodontitis.

Authors:  Peter Riis Hansen; Palle Holmstrup
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

6.  Chlamydial and periodontal pathogens induce hepatic inflammation and fatty acid imbalance in apolipoprotein E-deficient mice.

Authors:  Kati Hyvärinen; Anita M Tuomainen; Saara Laitinen; Igor L Bykov; Liisa Törmäkangas; Kai Lindros; Reijo Käkelä; Georg Alfthan; Irma Salminen; Matti Jauhiainen; Petri T Kovanen; Maija Leinonen; Pekka Saikku; Pirkko J Pussinen
Journal:  Infect Immun       Date:  2009-05-18       Impact factor: 3.441

7.  Local and systemic responses in matrix metalloproteinase 8-deficient mice during Porphyromonas gingivalis-induced periodontitis.

Authors:  Heidi Kuula; Tuula Salo; Emma Pirilä; Anita M Tuomainen; Matti Jauhiainen; Veli-Jukka Uitto; Leo Tjäderhane; Pirkko J Pussinen; Timo Sorsa
Journal:  Infect Immun       Date:  2008-11-24       Impact factor: 3.441

8.  Increased levels of leukocyte-derived MMP-9 in patients with stable angina pectoris.

Authors:  Simon Jönsson; Anna Lundberg; Hanna Kälvegren; Ida Bergström; Aleksander Szymanowski; Lena Jonasson
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

9.  Serum lipopolysaccharide activity is associated with the progression of kidney disease in finnish patients with type 1 diabetes.

Authors:  Mariann Nymark; Pirkko J Pussinen; Anita M Tuomainen; Carol Forsblom; Per-Henrik Groop; Markku Lehto
Journal:  Diabetes Care       Date:  2009-06-05       Impact factor: 19.112

10.  Pro-atherogenic lung and oral pathogens induce an inflammatory response in human and mouse mast cells.

Authors:  Anna Oksaharju; Jani Lappalainen; Anita M Tuomainen; Pirkko J Pussinen; Mirja Puolakkainen; Petri T Kovanen; Ken A Lindstedt
Journal:  J Cell Mol Med       Date:  2009-01       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.